Inhalable COVID-19 Vaccine Shows Promise in Rodent Model

Researchers have created an inhalable COVID-19 vaccine that is shelf stable at room temperature for up to three months, targets the lungs specifically and effec

Related Keywords

United States ,American ,Xianyun Wang ,Randallb Terry Jr ,Kristend Popowski ,C Todd Demarco ,Jada Davenport ,Thomasn Denny ,Juan Abad ,Zhenzhen Wang ,Mallory Flanagan ,Phuong Uyenc Dinh ,Jaewook Chung ,Jorge Piedrahita ,Dylan Silkstone ,Mengrui Liu ,Zhenhua Li ,Elizabeth Belcher ,Dashuai Zhu ,Halle Lutz ,Asma Ghodsi ,Arianna George ,American Heart Association ,Department Of Molecular Biomedical Sciences ,National Institutes Of Health ,Department Of Biomedical Engineering ,University Of North Carolina At Chapel Hill ,Hill Joint Department Of Biomedical Engineering ,Duke University ,Carolina State University ,Distinguished Professor ,Regenerative Medicine ,Chapel Hill Joint Department ,Biomedical Engineering ,Chapel Hill ,Extracellular Vesicle ,Nature Biomedical ,National Institutes ,American Heart ,North Carolina State University ,Xsome Biotech ,Molecular Biomedical Sciences ,Joint Department ,North Carolina ,Nicole De Naeyer ,North Carolina State ,Newswise ,Ovid 19 Exosomes Sars Cov 2 Rbd Inhalable Vaccine ,All Journal News ,Infectious Diseases ,Vaccines ,Coronavirus ,Ature Journal ,Ocial Media Distr Auto For Marked Clients ,